Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$88.19

1.08 (1.24%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:10
01/08/18
01/08
06:10
01/08/18
06:10

Piper wonders if Microsoft is better than bitcoin

In a research note titled "Better Than Bitcoin?," Piper Jaffray analyst Alex Zukin updated his investment thesis on Microsoft and formally rolled out estimates for 2019. Azure revenues are still growing close to triple digits and channel checks suggest that the company's pipeline of Office 365 remain robust, Zukin tells investors in a research note. He believes his investment thesis on the shares is resonating and reiterates an Overweight rating on Microsoft with a $115 price target. The software giant closed Friday up $1.08 to $88.19. The analyst calls Azure the "single largest growth opportunity" at Microsoft.

MSFT

Microsoft

$88.19

1.08 (1.24%)

BITCOIN

Bitcoin

$0.00

(0.00%)

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

MSFT Microsoft
$88.19

1.08 (1.24%)

12/12/17
BERN
12/12/17
NO CHANGE
Target $100
BERN
Outperform
Survey shows continued momentum for Microsoft Azure, says Bernstein
Bernstein analyst Mark Moerdler says his firm's IT Hardware semi-annual CIO survey shows that Microsoft (MSFT) Azure continues to gain mindshare and momentum within enterprise IT departments, and that Azure's customer count could be equal to or more than Amazon (AMZN) Web Services among enterprise user, he adds. The analyst notes that the continued momentum fully supports his thesis regarding the Microsoft Commercial Cloud opportunity and should support Azure revenue growth of about 90%, if not faster, for multiple quarters to come. He reiterates an Outperform rating and $100 price target on Microsoft shares.
12/20/17
BMOC
12/20/17
NO CHANGE
Target $142
BMOC
Market Perform
Red Hat results solid, but expectations already high, says BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Red Hat (RHT) to $142 from $128, stating that the company's results were solid across all metrics but he believes high expectations overshadowed the strong results. While saying he thinks Red Hat is the best-positioned hybrid cloud provider, valuation leaves him with a Market Perform rating on the stock and a preference toward Microsoft (MSFT) and VMware (VMW) in terms of hybrid cloud stocks.
12/20/17
OPCO
12/20/17
NO CHANGE
Target $100
OPCO
Outperform
Microsoft price target raised to $100 from $92 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Microsoft to $100 from $92 saying he sees it as the best large-cap stock in his coverage given high operating leverage from accelerating cloud growth. The analyst believes 2018 is going to be "a very strong year" for cloud services and infrastructure, and a better one for legacy telcos. He reiterates an Outperform rating on the shares.
01/02/18
DBAB
01/02/18
NO CHANGE
Target $150
DBAB
Buy
Deutsche tells Red Hat investors to not overreact to Amazon linux launch
Amazon (AMZN) Web Services prior to the holidays announced the launch of Amazon Linux 2, a free and updated version of their Linux-based server operating system that competes with Red Hat (RHT), Microsoft (MSFT) and others, Deutsche Bank analyst Karl Keirstead tells investors in a research note. New features include longer-term support and faster boot times, but the most interesting attribute is the ability to deploy Amazon Linux on-premise on virtualized servers running VMware (VMW) or Microsoft hypervisors, Keirstead tells investors. He says that while added competition, especially from Amazon, "is hardly a good thing" for Red Hat, investors should not overreact to the news. The analyst notes the Amazon Linux 2 rollout will take time and that it may compete with free Ubuntu/CentOS more than Red Hat's paid RHEL. Amazon's move results "in only a modest dent to our bullish call on Red Hat shares," Keirstead writes. He keeps a Buy rating on the stock with a $150 price target.
BITCOIN Bitcoin
$0.00

(0.00%)

11/29/17
STPT
11/29/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $20,000 from $14,000
Standpoint Research analyst Ronnie Moas raised his 2018 price target for bitcoin to $20,000 from $14,000. The current price is around $10,720 and the split-adjusted price is now $12,740 when factoring in Bitcoin Cash, Bitcoin Gold and Bitcoin Diamond, Moas tells investors in an intraday email. There is "no way to justify" gold investments equaling 40 times than that of bitcoin, the analyst argues. He thinks an argument can be made that bitcoin will be equal to gold in 10-15 years. Currently, gold has $7T in investments to bitcoin's $180B, according to Moas.
12/07/17
MSCO
12/07/17
NO CHANGE
MSCO
Morgan Stanley says TD Ameritrade most likely discount broker to embrace bitcoin
Given recent regulatory approval and the upcoming launch of bitcoin futures trading on CME (CME) and CBOE (CBOE), Morgan Stanley analyst Michael Cyprys said he expects discount brokers including E-Trade (ETFC), TD Ameritrade (AMTD) and Ally Financial (ALLY) to offer bitcoin futures trading within the next few months. Among them, he views TD Ameritrade as most likely to embrace bitcoin and lead the way and Charles Schwab (SCHW) as likely to be a latecomer. Cyprys added that he was surprised, given its status as a "challenger brand," that E-Trade has said it will take "a wait-and-see" approach.
12/07/17
STPT
12/07/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $28,000 from $20,000
Standpoint Research analyst Ronnie Moas this morning raised his 2018 price target for bitcoin to $28,000 from $20,000. Just over a week ago the analyst raised his 2018 target to $20,000 from $14,000. Moas points out that his longer term public target remains $50,000. He points out in an email that unlike the U.S. dollar, where the government can print money, the supply of bitcoin is capped. We are a couple of years away from being in a situation where hundreds of millions of people around the world are trying to get their hands on a few million bitcoin, Moas contends.
12/20/17
PIPR
12/20/17
NO CHANGE
Target $46
PIPR
Neutral
Piper ups Metropolitan Bank estimates on cryptocurrency exposure
Piper Jaffray analyst Matthew Breese raised his earnings estimates for Metropolitan Bank by 6% after the company detailed its exposure to a cryptocurrency exchange. Metropolitan's exposure to a cryptocurrency exchange averaged $245M in Q3, or 16% of total deposits, Breese tells investors in a research note. He estimate these items aggregate to 7% of net interest income and 9%-11% of earnings. Yesterday's disclosure is important on both the impact of earnings, the percentage of deposits tied to one customer, and that the bank has exposure to a "controversial industry," Breese tells investors in a research note. The analyst, despite raising his earnings estimates, keeps a Neutral rating on Metropolitan Bank shares with a $46 price target. He views the company's cryptocurrency exposure as a "double-edged sword for the stock." On the one hand, cryptocurrencies represent a "unique source of potential earnings growth" for Metropolitan, Breese writes. On the other, the volatility and potential regulatory concerns surrounding cryptocurrencies may cause some trepidation for traditional depository investors, the analyst adds.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$79.27

0.4 (0.51%)

11:46
05/22/18
05/22
11:46
05/22/18
11:46
Technical Analysis
Technical Take: Energy Select Sector SPDR hits new 52-week high »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$85.71

-3.64 (-4.07%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Recommendations
BioMarin analyst commentary  »

BioMarin 'raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

DO

Diamond Offshore

$20.60

0.71 (3.57%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Options
Diamond Offshore call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$104.25

0.17 (0.16%)

11:41
05/22/18
05/22
11:41
05/22/18
11:41
Conference/Events
Albemarle management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 04

    Jun

  • 05

    Jun

GIS

General Mills

$42.00

0.23 (0.55%)

11:40
05/22/18
05/22
11:40
05/22/18
11:40
Conference/Events
General Mills management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

MYND

MYnd Analytics

$2.66

-0.5 (-15.82%)

11:33
05/22/18
05/22
11:33
05/22/18
11:33
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$620.18

-45.5 (-6.84%)

11:32
05/22/18
05/22
11:32
05/22/18
11:32
Technical Analysis
Technical Take: AutoZone back near lows of the day »

After a brief bounce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TJX

TJX

$87.50

2.84 (3.35%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Earnings
TJX sees Q2 revenue approx. $9B, consensus $8.47B »

Expects wage increases to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RCII

Rent-A-Center

$10.07

-0.14 (-1.37%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Options
Notable ratio spread in Rent A Center »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$86.77

2.11 (2.49%)

11:28
05/22/18
05/22
11:28
05/22/18
11:28
Earnings
TJX sees FY19 revenue $37.7B-$37.9B, consensus $37.87B »

Expects pretax profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TGT

Target

$76.39

-0.47 (-0.61%)

, AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

11:27
05/22/18
05/22
11:27
05/22/18
11:27
Earnings
On The Fly: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$76.39

-0.47 (-0.61%)

AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

WMT

Walmart

$84.33

-0.17 (-0.20%)

SHLD

Sears

$3.35

-0.29 (-7.97%)

JCP

J.C. Penney

$2.41

-0.1 (-3.99%)

KSS

Kohl's

$61.15

-4.32 (-6.60%)

W

Wayfair

$84.92

-0.6 (-0.70%)

TSLA

Tesla

$277.25

-7.24 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 01

    Jun

  • 04

    Jun

  • 19

    Jun

11:25
05/22/18
05/22
11:25
05/22/18
11:25
Conference/Events
RBC commodity strategist to hold a luncheon meeting »

Group Luncheon Meeting,…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary  »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ADSK

Autodesk

$138.56

1.05 (0.76%)

11:20
05/22/18
05/22
11:20
05/22/18
11:20
Options
Autodesk calls active ahead of earnings »

Autodesk calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

TJX

TJX

$86.18

1.52 (1.80%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Hot Stocks
TJX 'disproportionally' attracting millennial customers »

TJX "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/22/18
05/22
11:16
05/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/18
05/22
11:15
05/22/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

TJX

TJX

$86.14

1.48 (1.75%)

11:13
05/22/18
05/22
11:13
05/22/18
11:13
Recommendations
TJX analyst commentary  »

JPMorgan stays Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

CCJ

Cameco

$10.72

-0.66 (-5.80%)

11:10
05/22/18
05/22
11:10
05/22/18
11:10
Options
Call buyers in Cameco as shares see relative weakness »

Call buyers in Cameco as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$41.71

0.38 (0.92%)

11:08
05/22/18
05/22
11:08
05/22/18
11:08
Conference/Events
Suncor management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

SAGE

Sage Therapeutics

$161.81

-1.43 (-0.88%)

11:04
05/22/18
05/22
11:04
05/22/18
11:04
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.